SeqDiagnostics Information

SeqDiagnostics (SeqDx) develops sequencing-based diagnostics for respiratory infections. Our first assay, NTM-Seq, identifies nontuberculous mycobacteria (NTM) to the species level across 170+ species, resolves M. abscessus to subspecies, and reports genotypic resistance markers. NTM-Seq is available in two workflows: • NTM-Seq Direct: targeted hybrid capture sequencing directly from sputum or BAL, with no culture step. 3 days from receipt. • NTM-Seq Culture: whole-genome sequencing from positive liquid culture bottles and isolates. 2 days from receipt. Testing is performed in our CLIA-certified laboratory in West Chicago, Illinois. NTM-Seq is a laboratory-developed test. We work with hospital and reference laboratories, pulmonology and infectious disease teams, and pharma and biotech sponsors running respiratory clinical trials. seqdiagnostics.com